https://www.selleckchem.com/pr....oducts/pyrvinium.htm
18 (1.03,1.36) p=0.02] or weight gain [HR 1.20 (1.04,1.38) p=0.01]. The association between weight change and CV events was stronger among participants with BMI 25 kg/m for 10% weight loss [HR 1.34 (1.08,1.66) p=0.001] and 10% weight gain [1.74 (1.41,2.24) p0.001]. Patients with greater variability in weight had a higher risk of CV events. Recent changes and high variability in weight predict CV events in RA, particularly among thin patients. Further study is necessary to determine if weight fluctuation has adverse cardiometab
Beğen
Yorum Yap
Paylaş
